The Food and Drug Administration (FDA) issued a Drug Safety Communication on July 9, 2015, stating that the agency intends to amend the cardiovascular warning on non-aspirin NSAIDs to state that these medicines can increase the risk of heart attack or stroke in patients with or without heart disease or risk factors for heart disease. The change will first be applied to prescription products and then to over-the-counter (OTC) non-aspirin NSAIDs, including the active ingredients ibuprofen, ketoprofen, and naproxen sodium.

To ensure you are using non-aspirin NSAIDs to treat your minor pain and fever safely, read and follow the label and talk to your doctor if you have any questions.